BB Biotech AG/ CH0038389992 /
2024-08-02 7:07:42 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
48.0000USD | - | 20 Turnover: 960 |
-Bid Size: - | -Ask Size: - | 2.54 bill.USD | - | - |
GlobeNewswire
03-28
Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second ...
GlobeNewswire
2021-06-17
Aleva Neurotherapeutics Recruits First Patient into its PMCF Study with its directSTIM™ Directional ...
GlobeNewswire
2019-12-16
Aleva Neurotherapeutics Receives CE Mark for its directSTIM™ Deep Brain Stimulation System and Raise...
GlobeNewswire
2018-10-19
Global Neurostimulation Devices Market Report 2018-2030: Focus on Invasive Devices Such as SCS, DBS,...
GlobeNewswire
2018-01-02
Radius Health Welcomes Elhan Webb as Head of Investor Relations and External Communications
GlobeNewswire
2017-10-19
Cidara Therapeutics Announces Pricing of $20 Million Private Placement of Common Stock
GlobeNewswire
2016-12-02
Successful launch of BB Healthcare Trust plc on the London Stock Exchange - initial issue volume GBP...
GlobeNewswire
2016-07-29
Bellevue Group with half-year operating profit of CHF 6.8 mn - increase of assets under management t...
GlobeNewswire
2016-07-15
BB Biotech AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the...
GlobeNewswire
2016-07-14
BB Biotech AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim o...